Action Potential Venture Capital
Status
ACTIVE
Global HQ
Scotts Valley, USA
Countries of investment
- USA
- Canada
Investment stages
- Seed
- Series A
- Series B
Industries
- Health Tech
- Biotechnology
- Pharma
- Medical Devices
- Digital Health
About
Action Potential Venture Capital (APVC) is a leading medtech venture capital firm founded by GSK in 2013. APVC invests globally in startups advancing bioelectronic medicines and enabling technologies. They actively support innovation in neural interfacing and electroceuticals.
Action Potential Venture Capital (APVC) is a leading medtech venture capital firm founded by GSK in 2013. APVC invests globally in startups advancing bioelectronic medicines and enabling technologies. They actively support innovation in neural interfacing and electroceuticals.
Investment Thesis
APVC is dedicated to bringing bioelectronic medicines to patients by supporting innovators and entrepreneurs pioneering a bioelectronic future.
Manager's Experience
Top-tier fund concentrating on early-stage biotechnology and healthcare ventures. Engaged in over 30 investments primarily in the US, with a notable focus on companies that demonstrate innovative therapeutic solutions. Recognized for a hands-on, operator-led approach and a successful track record of multiple high-profile IPOs. Committed to fostering strong partnerships with emerging entrepreneurs to drive growth and value creation.
Team
Jua
Imran Eba
Portfolio
Alpheus Medical
Cala Health
CVRx
Exo Imaging
MicroTransponder
Neuspera
Onc AI
Presidio Medical
Saluda Medical
SetPoint Medical.